Drug maker, Merck & Co; Inc. (NYSE: MRK) announced on Tuesday that it plans to cut 8,500 jobs as part of its bigger plan to streamline its research and development and improve its commercial focus. The Whitehouse Station, N.J; based Company expects to save nearly $2.5 billion in annual costs by the end of year [...]
Shares of PMC-Sierra Inc. (NASDAQ: PMCS), a designer, developer and marketer of semiconductor solutions through a network of offices in North America, are seeing a huge rally in trading today after the company reported its fourth-quarter financial results. [...]
Merck & Co Inc. (NYSE: MRK), a New Jersey-based global healthcare company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health and consumer care products, which it markets directly and through its joint ventures, today reported results for the third quarter ended September 30, 2012. [...]
Drug maker Merck & Co Inc. (NYSE: MRK) reported better-than-expected fiscal second-quarter earnings on Friday, driven mainly by strong sales of vaccines and treatments for both HIV and diabetes, offsetting the impact of rising U.S. dollar. [...]
Merck & Co. Inc (NYSE: MRK) decided to wrap up an advanced study of its osteoporosis drug, since the initial examination confirmed the effectiveness of the drug. [...] |
|
|
|
Copyright © 2024 Daily Stocks News - All Rights Reserved Powered by WordPress & Atahualpa |
||
Recent Comments